Chemoinformaics analysis of 2,5-Dihydroxy-4-methoxy-9H-fluoren-9-one
| Molecular Weight | 242.23 | nRot | 1 |
| Heavy Atom Molecular Weight | 232.15 | nRig | 16 |
| Exact Molecular Weight | 242.058 | nRing | 3 |
| Solubility: LogS | -4.508 | nHRing | 0 |
| Solubility: LogP | 2.804 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 33.2559 |
| nHD | 2 | BPOL | 12.6361 |
| QED | 0.687 |
| Synth | 2.248 |
| Natural Product Likeliness | 1.565 |
| NR-PPAR-gamma | 0.877 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.004 |
| HIA | 0.009 |
| CACO-2 | -4.811 |
| MDCK | 0.0000151 |
| BBB | 0.11 |
| PPB | 0.963517 |
| VDSS | 0.637 |
| FU | 0.0256191 |
| CYP1A2-inh | 0.892 |
| CYP1A2-sub | 0.79 |
| CYP2c19-inh | 0.169 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.413 |
| CYP2c9-sub | 0.835 |
| CYP2d6-inh | 0.589 |
| CYP2d6-sub | 0.568 |
| CYP3a4-inh | 0.762 |
| CYP3a4-sub | 0.179 |
| CL | 9.152 |
| T12 | 0.502 |
| hERG | 0.034 |
| Ames | 0.875 |
| ROA | 0.237 |
| SkinSen | 0.105 |
| Carcinogencity | 0.371 |
| EI | 0.959 |
| Respiratory | 0.174 |
| NR-Aromatase | 0.529 |
| Antiviral | Yes |
| Prediction | 0.718282 |